Nguyen N P, Moltz C C, Frank C, Vos P, Smith H J, Karlsson U, Dutta S, Midyett F A, Barloon J, Sallah S
Radiation Oncology, VA North Texas Health Care System, Dallas 75216, USA.
Ann Oncol. 2004 Mar;15(3):383-8. doi: 10.1093/annonc/mdh101.
To assess the prevalence, severity and morbidity of dysphagia following concurrent chemoradiation for head and neck cancer.
Patients who underwent chemotherapy and radiation for head and neck malignancies were evaluated for their ability to resume oral feeding following treatment. Modified barium swallow (MBS) studies were performed if the patients complained of dysphagia or if there was clinical suspicion of aspiration. The severity of dysphagia was graded on a scale of 1-7. If significant abnormalities were found, swallowing studies were repeated until resolution of dysphagia.
Between March 1999 and May 2002, 55 patients with locally advanced head and neck cancer underwent concurrent chemotherapy and radiation. Aspiration pneumonia was observed in eight patients, three during treatment and five following treatment. Five patients died from pneumonia. Two patients developed respiratory failure requiring intubation as a complication of pneumonia. At a median follow-up of 17 months (range 6-48 months), 25 patients (45%) developed severe dysphagia requiring prolonged tube feedings for more than 3 months (22 patients) or repeated dilatations (three patients). Among 33 patients who underwent MBS following treatment, 12 patients (36%) had silent aspiration (grade 6-7 dysphagia). Thirteen patients (39%) developed grade 4-5 dysphagia which required prolonged enteral nutritional support to supplement their oral intake. Most patients had severe weight loss (0-21 kg) during treatment, likely due in part to mucositis in the orodigestive tube.
Dysphagia is a common, debilitating and potentially life-threatening sequela of concurrent chemoradiation for head and neck malignancy. Physicians should be aware that the clinical manifestations of aspiration may be unreliable and insidious, because of the depressed cough reflex. Modified and traditional barium swallows should be performed following treatment to assess the safety of oral feeding and the structural integrity of the pharynx and esophagus. Patients with severe dysphagia may benefit from rehabilitation. Tube feeding should be continued for those with aspiration.
评估头颈部癌同步放化疗后吞咽困难的发生率、严重程度及发病率。
对头颈部恶性肿瘤接受化疗和放疗的患者,评估其治疗后恢复经口进食的能力。若患者主诉吞咽困难或临床怀疑有误吸,则进行改良吞钡检查(MBS)。吞咽困难的严重程度按1 - 7级进行分级。若发现明显异常,则重复吞咽检查,直至吞咽困难缓解。
1999年3月至2002年5月期间,55例局部晚期头颈部癌患者接受了同步化疗和放疗。8例患者发生吸入性肺炎,3例发生在治疗期间,5例发生在治疗后。5例患者死于肺炎。2例患者因肺炎并发症发生呼吸衰竭,需要插管。中位随访17个月(范围6 - 48个月)时,25例患者(45%)出现严重吞咽困难,需要长期管饲超过3个月(22例患者)或反复扩张(3例患者)。在33例治疗后接受MBS检查的患者中,12例患者(36%)存在隐匿性误吸(吞咽困难6 - 7级)。13例患者(39%)出现4 - 5级吞咽困难,需要长期肠内营养支持以补充经口摄入量。大多数患者在治疗期间体重严重下降(0 - 21千克),这可能部分归因于口腔消化道的黏膜炎。
吞咽困难是头颈部恶性肿瘤同步放化疗常见、使人衰弱且可能危及生命的后遗症。医生应意识到,由于咳嗽反射减弱,误吸的临床表现可能不可靠且隐匿。治疗后应进行改良和传统吞钡检查,以评估经口进食的安全性以及咽和食管的结构完整性。严重吞咽困难的患者可能从康复治疗中获益。有误吸的患者应继续管饲。